MS Hershfield

423 total citations
8 papers, 317 citations indexed

About

MS Hershfield is a scholar working on Genetics, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, MS Hershfield has authored 8 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 2 papers in Epidemiology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in MS Hershfield's work include Virus-based gene therapy research (3 papers), Acute Myeloid Leukemia Research (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). MS Hershfield is often cited by papers focused on Virus-based gene therapy research (3 papers), Acute Myeloid Leukemia Research (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). MS Hershfield collaborates with scholars based in United States, Thailand and Australia. MS Hershfield's co-authors include Waldmann Ta, BF Haynes, J O Moore, Joanne Kurtzberg, Wichittra Tassaneeyakul, J. Callaghan, Ellen M. McDonagh, Teri E. Klein, Yoshiro Saito and Taisei Mushiroda and has published in prestigious journals such as Blood, Journal of Allergy and Clinical Immunology and Clinical Pharmacology & Therapeutics.

In The Last Decade

MS Hershfield

7 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MS Hershfield United States 6 108 97 69 59 56 8 317
Jason Law United States 8 71 0.7× 153 1.6× 34 0.5× 26 0.4× 90 1.6× 20 358
Janel Long-Boyle United States 15 283 2.6× 108 1.1× 154 2.2× 87 1.5× 91 1.6× 43 578
Hironobu Hyodo Japan 15 107 1.0× 299 3.1× 122 1.8× 9 0.2× 88 1.6× 39 582
John N. Bickers United States 10 144 1.3× 27 0.3× 86 1.2× 12 0.2× 134 2.4× 17 369
Felipe Sandoval United States 11 155 1.4× 63 0.6× 22 0.3× 11 0.2× 89 1.6× 19 340
A Drochmans Belgium 10 38 0.4× 29 0.3× 31 0.4× 14 0.2× 104 1.9× 21 425
İnci Yıldız Türkiye 13 122 1.1× 49 0.5× 133 1.9× 9 0.2× 160 2.9× 37 383
Victor Hoffbrand United Kingdom 11 203 1.9× 49 0.5× 90 1.3× 11 0.2× 73 1.3× 18 393
J Janssen Netherlands 7 105 1.0× 60 0.6× 20 0.3× 25 0.4× 83 1.5× 14 327
Motohiro Arao Japan 10 46 0.4× 53 0.5× 9 0.1× 11 0.2× 45 0.8× 17 427

Countries citing papers authored by MS Hershfield

Since Specialization
Citations

This map shows the geographic impact of MS Hershfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MS Hershfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MS Hershfield more than expected).

Fields of papers citing papers by MS Hershfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MS Hershfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MS Hershfield. The network helps show where MS Hershfield may publish in the future.

Co-authorship network of co-authors of MS Hershfield

This figure shows the co-authorship network connecting the top 25 collaborators of MS Hershfield. A scholar is included among the top collaborators of MS Hershfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MS Hershfield. MS Hershfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Saito, Yoshiro, MS Hershfield, Ellen M. McDonagh, et al.. (2015). Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA‐B) genotype and allopurinol dosing: 2015 update. Clinical Pharmacology & Therapeutics. 99(1). 36–37. 116 indexed citations
2.
Hershfield, MS, et al.. (2006). 骨髄準備調節無しの幹細胞遺伝子治療されたADA-欠損症患者で達成される定常的に進行する血液学的、免疫学的再構成. The Journal of Gene Medicine. 8(12). 1442. 1 indexed citations
3.
Hershfield, MS. (1993). Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase (PEG-ADA).. PubMed. 4(1-4). 93–7. 10 indexed citations
4.
Ochs, HD, et al.. (1992). Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency. Blood. 80(5). 1163–1171. 42 indexed citations
5.
Kurtzberg, Joanne, et al.. (1989). CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood. 73(2). 381–390. 126 indexed citations
6.
Ta, Waldmann, et al.. (1989). CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood. 73(2). 381–390. 12 indexed citations
8.
Hershfield, MS, et al.. (1973). In vitro characterization of a mutator T4 DNA polymerase.. PubMed. 73. Suppl 73:131–6. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026